AI assistant
Guerbet — Earnings Release 2009
May 7, 2009
1392_10-q_2009-05-07_0c116fe6-3141-4040-8a19-bf81b18c9120.pdf
Earnings Release
Open in viewerOpens in your device viewer
Press release
2009 first-quarter sales
Villepinte, 7 May 2009
Consolidated group sales (IFRS):
| In thousands of euros | 2009 | 2008 | Change |
|---|---|---|---|
| Total first quarter……………………… | 79,031 | 75,573 | +4.6% |
Consolidated sales by region
| In thousands of euros | 2009 | 2008 | Variation |
|---|---|---|---|
| Europe | 64,279 | 61,132 | +5.1% |
| Other markets | 14,753 | 14,441 | +2.2% |
| Total……………………………………… | 79,031 | 75,573 | +4.6% |
2009 first-quarter sales and outlook
Sales in the first quarter of 2009 grew 4.6% over the same period last year on gains in Europe where Xenetix has resumed growth (+10% in volume and +2.9% in value) and Dotarem has continued to advance (+22.5% in volume and +15.0% in value).
In other world markets, Group sales have continued to underperform relative to their potential and were adversely affected by a negative currency effect of 4.3% on sales in relation to the 2008 first quarter, particularly in Brazil and South Korea.
For the full year, the Group confirms its forecast for annual sales growth comparable to that of the prior year.
Contact: Finance Department. Tel: +33(0)1 45 91 50 11